The role of the microbiome in cancer development and therapy

Роль микробиома в развитии и терапии рака
Aadra Prashant Bhatt, Matthew R. Redinbo, Scott J. Bultman
2017-05-08

cancer microbiomecheckpoint immunotherapygnotobiotic mouse modelsmicrobiome dysbiosistumorigenesis
Answer questions and earn CME/CNE The human body harbors enormous numbers of microbiota that influence cancer susceptibility, in part through their prodigious metabolic capacity and their profound influence on immune cell function. Microbial pathogens drive tumorigenesis in 15% to 20% of cancer cases. Even larger numbers of malignancies are associated with an altered composition of commensal microbiota (dysbiosis) based on microbiome studies using metagenomic sequencing. Although association studies cannot distinguish whether changes in microbiota are causes or effects of cancer, a causative role is supported by rigorously controlled preclinical studies using gnotobiotic mouse models colonized with one or more specific bacteria. These studies demonstrate that microbiota can alter cancer susceptibility and progression by diverse mechanisms, such as modulating inflammation, inducing DNA damage, and producing metabolites involved in oncogenesis or tumor suppression. Evidence is emerging that microbiota can be manipulated for improving cancer treatment. By incorporating probiotics as adjuvants for checkpoint immunotherapy or by designing small molecules that target microbial enzymes, microbiota can be harnessed to improve cancer care. CA Cancer J Clin 2017;67:326-344. © 2017 American Cancer Society.
1
Dysbiosis is associated with many additional malignancies, although association studies cannot establish whether microbiome changes cause or result from cancer.
2
Gnotobiotic mouse studies support a causal role for microbiota in altering cancer susceptibility and progression.
3
Manipulating microbiota with probiotics or small molecules targeting microbial enzymes may improve cancer treatment, including checkpoint immunotherapy.
4
Microbial pathogens contribute causally to tumorigenesis in approximately 15%–20% of cancer cases.
5
Microbiota influence cancer through inflammation modulation, DNA damage induction, and production of metabolites that promote oncogenesis or tumor suppression.

Human microbiota and their interactions with cancer

The influence of microbiota composition and microbial activities on cancer susceptibility, tumorigenesis, progression, and response to therapy

Publication Details
Publication Date
2017-05-08
Journal
Publisher
ISSN
Cited by
698
Access Type
Author Information
Authors
Aadra Prashant Bhatt
Matthew R. Redinbo
Scott J. Bultman
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%